Monthly Archives: October 2020

9 Meters Biopharma (NMTR) Gets a Buy Rating from Maxim Group

9 Meters Biopharma (NMTR – Research Report) received a Buy rating and a $3.00 price target from Maxim Group analyst Jason McCarthy yesterday. The company’s shares closed last Friday at $0.65. According to TipRanks.com, McCarthy is a 5-star analyst with

The General Counsel, VP & Sec. of Ares Capital (NASDAQ: ARCC) is Buying Shares

Yesterday, the General Counsel, VP & Sec. of Ares Capital (ARCC – Research Report), Joshua Bloomstein, bought shares of ARCC for $68.89K. Following this transaction Joshua Bloomstein’s holding in the company was increased by 58.82% to a total of $229.7K.

Raymond James Maintains a Buy Rating on Chevron (CVX)

In a report issued on July 28, Pavel Molchanov from Raymond James maintained a Buy rating on Chevron (CVX – Research Report). The company’s shares closed last Friday at $69.50. According to TipRanks.com, Molchanov is a 4-star analyst with an

Alphabet Class C (GOOG) Received its Third Buy in a Row

After Raymond James and Oppenheimer gave Alphabet Class C (NASDAQ: GOOG) a Buy rating last month, the company received another Buy, this time from Mizuho Securities. Analyst Mizuho Securities maintained a Buy rating on Alphabet Class C yesterday and set

Macquarie Downgrades Aspira Women’s Health (AWH) to Hold

Aspira Women’s Health (AWH – Research Report) received a Hold rating from Macquarie analyst Macquarie on December 2. The company’s shares closed last Friday at $3.77. The word on The Street in general, suggests a Moderate Buy analyst consensus rating

Analysts Offer Insights on Technology Companies: and Fiverr International (NYSE: FVRR)

There’s a lot to be optimistic about in the Technology sector as 1 analysts just weighed in on and Fiverr International (FVRR – Research Report) with bullish sentiments. TipRanks has tracked 36,000 company insiders and found that a few of